Impact of Influenza Vaccine in reducing adverse events in patients with recent heart attack
Phase 4
- Conditions
- Health Condition 1: I219- Acute myocardial infarction, unspecified
- Registration Number
- CTRI/2024/05/067056
- Lead Sponsor
- Indian Council of Medical Research, India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients > 45 year old with physician diagnosed MI (ST elevation and non ST elevation) in the previous 12 weeks consenting to participate will be randomized to intervention or control arm
Exclusion Criteria
1) Anaphylactic reaction to a previous dose of influenza vaccine,
2) IgE-mediated hypersensitivity to egg protein manifested as hives, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock;
3) Guillain-Barré syndrome within eight weeks of a previous influenza vaccine;
4) Anaphylactic reaction to neomycin
5) Influenza vaccine in the previous one year;
6) Plan to be vaccinated with flu vaccine in coming year
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method